Trxade Health, Inc. (NASDAQ:MEDS)

Medistem Inc. is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases. The company's lead product, the endometrial regenerative cell (ERC), is a "universal donor" stem cell being developed for critical limb ischemia

Web site: http://www.medisteminc.com

Last updated February 27, 2012